Providing Strategic Medical Guidance in Advancing HyBryte™ Clinical Development PRINCETON, N.J., Oct. 14, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare...
Hence then, the article about soligenix updates united states medical advisory board for cutaneous t cell lymphoma was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Soligenix Updates United States Medical Advisory Board for Cutaneous T-Cell Lymphoma )
Also on site :
- New Avatar Animated Series About Teen Kuruk Ordered At Paramount+, Seven Havens Scores Double Renewal
- Accident-Only vs. Accident-and-Illness Pet Insurance: What’s the Difference?
- ’80s Rock Band With Six Lead Singers Is Approaching Its Farewell Tour—and Fans Have a Major Date to Know